I’m honoured to be taking up my new role with @AlzResearchUK and look forward to contributing to the team effort needed to makes transformative changes to people living with, or at risk of, dementia @drcionucl
We’re delighted to announce our new Chief Medical Officer, @UCL’s Prof @jmschott, who will play a pivotal role in supporting and shaping ongoing research, policy, advocacy and strategy work to help deliver life-changing dementia research. Let’s #MakeBreakthroughsPossible!
A new trial launches today to see if a blood test can diagnose Alzheimer’s earlier and more accurately. It’s part of our Blood Biomarker Challenge and our Chief Medical Officer @jmschott says,
✍️ Lifestyle Interventions to Improve Cognition in Later Life - When is Enough Enough?
New @JAMA_current Editorial from UK DRI Group Leader Prof @jmschott following the presentation of primary results of US POINTER
👉 https://t.co/OXSkUvmtSS
Early trials results show that trontinemab may clear amyloid quicker than lecanemab and donanemab.
Roche, who manufactures the drug, are planning to run larger trials later this year to see if the drug canslow down the decline in memory and thinking in people with early Alzheimer’s, and in those at risk of developing the disease.
Read more in The @Telegraph: https://t.co/x3Yb8lgHHT
Editorial by @jmschott: The US POINTER study suggests that modest lifestyle interventions can enhance cognitive health in aging populations.
https://t.co/6IiMA0P0qI
#AAIC2025
🧠 Our Chief Medical Officer, Prof Jon Schott (@jmschott) just presented at #AAIC25 sharing important insights into early detection and disease progression from the Insight46 cohort #ARUKfunded
Latest @MRCLHA Insight 46 paper — TL/DR: midlife air pollution influences late life cognitive function. Full text @LancetLongevity https://t.co/ofWS2MFKUl
Pleased to be able to contribute to this huge international effort led by @RikOssenkoppele and colleagues @biofinder_study exploring tau PET in n=12,048 individuals *open access* paper here: https://t.co/IhgQ0meDN8
Are you a UK health professional working in dementia? If so, please take this *5 min* survey to help @AlzResearchUK better understand the views of HCPs working across the NHS. Thank you! https://t.co/bT7nUaT152
Yesterday, Anika brilliantly defended her PhD thesis on the fole of MTL in Alzheimer’s disease.
It was a brilliant discussion with @jmschott between peers.
Congratulations Dr. Wuestefeld! You did a great job👏👏👏
I’m honoured to be joining the DRI as a group leader — and look forward to helping translate the amazing science being done there into benefits for people with, and at risk of, dementia. @ARUKscientist@NIHRresearch@acmedsci@UCLBrainScience
We're excited to welcome a new Group Leader to the UK DRI at UCL! 🙌 🎉 🥳
Prof @jmschott’s clinical practice & research are centred on the dementias with a focus on early accurate diagnosis and detection of pre-symptomatic Alzheimer’s disease👉https://t.co/wJIa6mROuJ
Latest open access @MRCLHA Insight 46 paper — remote cognitive testing in a healthy elderly population is feasible #online46#cognitron
https://t.co/u0zVheDLA2
My son Otto is doing the London-Brighton cycle to raise funds for @ARUKscientist@AlzResearchUK next weekend — please support if you can! #JustGiving https://t.co/BLe8euooOR